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ABSTRACT: Fatty acid amide hydrolase (FAAH) is an integral membrane protein responsible for the
hydrolysis of a number of primary and secondary fatty acid amides, including the neuromodulatory
compounds anandamide and oleamide. Analysis of FAAH’s primary sequence reveals the presence of a
single predicted transmembrane domain at the extreme N-terminus of the enzyme. A mutant form of the
rat FAAH protein lacking this N-terminal transmembrane domain (¢TM-FAAH) was generated and, like
wild type FAAH (WT-FAAH), was found to be tightly associated with membranes when expressed in
COS-7 cells. Recombinant forms of WT- and ¢TM-FAAH expressed and purified from Escherichia
coli exhibited essentially identical enzymatic properties which were also similar to those of the native
enzyme from rat liver. Analysis of the oligomerization states of WT- and ¢TM-FAAH by chemical
cross-linking, sedimentation velocity analytical ultracentrifugation, and size exclusion chromatography
indicated that both enzymes were oligomeric when membrane-bound and after solubilization. However,
WT-FAAH consistently behaved as a larger oligomer than ¢TM-FAAH. Additionally, SDS-PAGE
analysis of the recombinant proteins identified the presence of SDS-resistant oligomers for WT-FAAH,
but not for ¢TM-FAAH. Self-association through FAAH’s transmembrane domain was further
demonstrated by a FAAH transmembrane domain-GST fusion protein which formed SDS-resistant dimers
and large oligomeric assemblies in solution.
Fatty acid amide hydrolase (FAAH)1 (1-5) is the only
identified mammalian member of a family of amidase
enzymes known as the “amidase signature” family (6).
Despite the presence of these enzymes in prokaryotic (6-
10) and eukaryotic (1, 11-13) organisms, little is yet known
about their catalytic mechanism and structural features.
Among the amidase signature enzymes, FAAH is of
particular interest due to the intriguing biological activities
of its fatty acid amide substrates. Several fatty acid amides,
including the neuromodulatory compounds anandamide and
oleamide, have recently been identified as important mam-
malian signaling molecules (14-18). Anandamide (arachi-
donoyl ethanolamide) was first characterized as an endog-
enous brain ligand for the CB1 cannabinoid receptor (15)
and has since been shown to possess cannabinoid-like
properties in vivo (19). Oleamide (9-Z-octadecenamide) was
isolated from the cerebrospinal fluid of sleep-deprived cats
(20), found to induce physiological sleep when injected into
rats (14), and shown to modulate 5-hydroxytryptamine (5-
HT) receptor responses to serotonin (21-23). FAAH is
highly expressed in neurons within the central nervous
system where the enzyme appears poised to inactivate fatty
acid amides at their presumed sites of action (24, 25).
Consistent with this notion, addition of FAAH inhibitors to
neuroblastoma cell cultures increased the amounts of anan-
damide (26) and oleamide (27) produced by these cells, and
FAAH-resistant analogues of anandamide have been shown
to induce prolonged inhibition of motor activity in rats (28).
Due to the hydrophobic nature of FAAH’s substrates,
intimate interactions between the enzyme and cell membranes
may be important for efficient rates of substrate hydrolysis
and product release. It is thus not surprising that unlike most
other amidase signature enzymes, FAAH is an integral
membrane protein, a feature which has in turn rendered the
structural and enzymological characterization of FAAH
particularly challenging. Defining the nature of FAAH’s
membrane interactions, as well as the role that these
associations play in the enzyme’s structure and function, may
prove essential to a deeper understanding of how FAAH
participates in the regulation of fatty acid amide signaling
in vivo.
Primary sequence analysis of the mouse, rat, and human
FAAH proteins predicts that these enzymes are type I integral
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membrane proteins with a single transmembrane domain
from amino acids 9 to 29 and a large cytoplasmic tail
containing the majority of the protein sequence (amino acids
30-579; TMpred and PSORT prediction programs). To
elucidate the role of the transmembrane domain in FAAH’s
membrane binding, catalytic, and self-association properties,
we have characterized an N-terminal transmembrane domain
deletion construct of rat FAAH (¢TM-FAAH) and compared
this mutant enzyme to the wild type protein (WT-FAAH).
EXPERIMENTAL PROCEDURES
Generation of FAAH Expression Constructs. The loca-
tions of potential transmembrane domains in human, mouse,
and rat FAAH were predicted using PSORT (http://psort-
.nibb.ac.jp:8800/form.html) and TMpred (http://www.isre-
c.isb-sib.ch/software/TMPRED_form.html) analysis pro-
grams. The ¢TM-FAAH construct for subcloning into the
eukaryotic expression vector pcDNA3 (Invitrogen) was
generated by PCR from the cloned rat WT-FAAH cDNA
using the following primers: sense primer, 5′-GCGGTAC-
CATGCGATGGACCGGGCGC-3′; and antisense primer, 5′-
GGTCTGGCCAAAGAGAGG-3′. The sense primer con-
tained an added KpnI site and in-frame ATG for creating an
artificial translation initiation site. An approximately 520
bp PCR product was generated, digested with KpnI-HindIII,
and subcloned into a KpnI-HindIII-digested WT-FAAH
pcDNA3 vector to generate the ¢TM-FAAH-pcDNA3
construct (amino acids 30-579). The WT-FAAH pcDNA3
construct has been described previously (1). The calculated
molecular masses of the COS-7-expressed WT- and ¢TM-
FAAH are 63.3 and 60.1 kDa, respectively. The ¢TM-
FAAH construct for subcloning into the prokaryotic expres-
sion vector pTrcHisA (Invitrogen) was generated by PCR
from the cloned rat FAAH cDNA using the following
primers: sense primer, 5′-GCCTCGAGACCGGGCGCCA-
GAAGG-3′; and antisense primer, 5′-GCGAATTCTCAC-
GATGGCTGCTTTTGAGG-3′. The resulting PCR product
was ligated into the pTrcHisA vector to generate an N-
terminally His-tagged ¢TM-FAAH construct (amino acids
32-579). A WT-FAAH cDNA was generated by PCR using
the following primers: sense primer, 5′-GCCTCGAG-
GATGGTGCTGAGCGAAG-3′; and antisense primer, 5′-
GCGAATTCCGATGGCTGCTTTTGAGG-3′. This cDNA
was ligated into the pTrcHis2C vector to generate a C-
terminally His-tagged WT-FAAH construct. The calculated
molecular masses of the Escherichia coli-expressed WT- and
¢TM-FAAH are 67.2 and 64.5 kDa, respectively. A
C-terminally His-tagged ¢TM-FAAH and N-terminally His-
tagged WT-FAAH were similarly generated. All constructs
were confirmed by sequencing in both directions.
Generation of a FAAH Transmembrane Domain-GST
Fusion Protein. A GST construct for subcloning into the
WT-FAAH-pTrcHis2 vector was generated by PCR from the
expression vector pGEX4T-3 (Amersham Pharmacia Bio-
tech) using the following primers: sense primer, 5′-CGC-
CCGGGGCATGTCCCCTATACTAGG-3′; and antisense
primer, 5′-CGGAATTCTAGATTAAACCAGATCCGA-
TTTTGG-3′. A cDNA containing the coding sequence of
GST with a 5′-SmaI site, 3′-EcoRI site, and 3′ stop codon
was thereby generated and ligated into the WT-FAAH
pTrcHis2C construct using an internal SmaI site of the rat
FAAH cDNA and a vector EcoRI site. The resulting
construct encoded a fusion protein containing residues 1-39
of FAAH and the entire GST sequence, terminating in a stop
codon so incorporation of the C-terminal His tag could be
prevented. The GST fusion vector pGEX4T-3 was used to
express wild type GST. The calculated molecular masses
of the expressed GST and TM-GST proteins are 27.8 and
30.0 kDa, respectively.
Generation of Anti-FAAH and Anti-GST Polyclonal An-
tibodies. Rabbit polyclonal antibodies were raised against
a FAAH-GST fusion protein (including amino acids 38-
579 of the rat FAAH protein) generated by standard
molecular biology procedures (Amersham Pharmacia Bio-
tech). Affinity purification of the anti-FAAH rabbit antibod-
ies was conducted by first depleting rabbit antiserum of GST-
cross reactive antibodies (which constituted affinity-purified
anti-GST antibodies) and then isolating from this serum the
FAAH-GST reactive antibodies.
COS-7 Expression and Analysis. Transient transfections,
immunofluorescence, and fractionation of COS-7 extracts
into cytosolic and membrane fractions were performed as
previously detailed, with an additional step where total cell
extracts were sonicated following Dounce homogenization
(12). Where indicated, membrane pellets were resuspended
in 200 íL of 100 mM Na2CO3 by sonication. The
resuspended pellet was incubated in 100 mM Na2CO3 for
30 min at 4 °C and then airfuged at 30 psi for 30 min. The
100 mM Na2CO3 supernatant was airfuged once more at 30
psi for 30 min, while the 100 mM Na2CO3 pellet was
resuspended in 200 íL of 100 mM Na2CO3. An analogous
protocol was employed for treating cell membranes under
high-salt conditions [1.0 M NaCl in a buffer of 12.5 mM
Hepes (pH 8.0) and 1 mM EDTA]. Protein concentrations
of each fraction were determined (Dc protein assay kit, Bio-
Rad), and 10 íg of protein from each fraction was analyzed
by standard SDS-PAGE and Western blotting procedures.
All SDS-PAGE protein samples, both here and in subse-
quently discussed studies (unless otherwise indicated), were
incubated in 2 loading buffer [125 mM Tris (pH 6.75),
20% glycerol, 4% SDS, 10% â-mercaptoethanol, and 0.005%
bromophenol blue] and heated for 5 min at 90 °C prior to
SDS-PAGE analysis. For analysis of FAAH activity in
intact COS-7 cells, [14C]oleamide [1 íCi, 50 íCi/ímol,
synthesized as described previously (14)] in ethanol (4 íL)
was added to 5 mL of complete medium (DMEM with
L-glutamine, nonessential amino acids, sodium pyruvate, and
10% fetal bovine serum), and the resulting solution was
applied to a 100 mM dish of transiently transfected COS-7
cells (on the second day of transfection, 80-90% conflu-
ency). Following a 15 min incubation at 37 °C, the medium
was removed, and the cells were washed with 2  5 mL
volumes of complete medium and then harvested by cell
scraping. The resulting cell suspension was extracted with
ethyl acetate (3 volumes), and the organic layer was removed
and concentrated under a stream of nitrogen. The dried
organic extract was resuspended in 20 íL of ethanol and
analyzed by thin layer chromatography (TLC; solvent
conditions of 55% ethyl acetate/hexanes; oleamide with an
Rf of 0.4), and radiolabeled lipids were quantified by
phosphorimaging (Packard). Relative oleamide concentra-
tions were calculated as percent values of the total radioac-
tivity on the TLC plates.
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Purification of WT- and ¢TM-FAAH from E. coli. The
WT- and ¢TM-FAAH proteins were expressed in the E. coli
BL21(DE3) strain by following manufacturer’s guidelines
(Invitrogen). Cultures were induced with 1 mM IPTG at an
OD600 of 0.6-0.7. The cultures were induced for 4 h and
pelleted at 5000g for 20 min. At this point, the cell pellets
could be frozen at -80 °C. The cells were resuspended in
80 mL of lysis buffer [50 mM Tris (pH 8.0), 100 mM NaCl,
and 1% Triton X-100], and lysozyme was added to a final
concentration of 1 mg/mL. Triton X-100 in the lysis buffer
was found to be necessary for recovery of both WT- and
¢TM-FAAH. After incubation on ice for 30 min, the lysate
was sonicated with a 50 W tip sonicator with six to ten 10
s pulses and centrifuged at 10000g for 35 min. The resulting
supernatant was added to a 2 mL bed volume of Talon cobalt
affinity resin (Clontech) and the mixture placed on a rotating
wheel for 30 min at room temperature. The beads were
collected by centrifugation at 700g for 5 min and washed in
batch with 30 mL of lysis buffer and twice with 30 mL of
lysis buffer and 10 mM imidazole before applying to a 1.5
 30 cm column. The column was washed once with 15
mL of lysis buffer and 10 mM imidazole, and the bound
protein eluted with 6 mL of elution buffer (lysis buffer and
200 mM imidazole). The eluted protein was next applied
to a 4 mL bed volume of heparin-agarose (Bio-Rad) pre-
equilibrated in the imidazole elution buffer. Heparin puri-
fication was carried out immediately following elution from
the Talon resin as the enzymatic activity was unstable to
freezing or prolonged storage at 4 °C in the imidazole elution
buffer. The column was rinsed sequentially with 15 mL of
imidazole elution buffer, 20 mL of buffer 1 [20 mM Hepes
(pH 7.8), 10% glycerol, 1 mM EDTA, and 0.5% CHAPS]
with 150 mM NaCl, and 20 mL of buffer 1 with 300 mM
NaCl. The purified ¢TM-FAAH was eluted with 6 mL of
buffer 1 with 700 mM NaCl, and WT-FAAH was eluted
with 6 mL of buffer 1 with 1.0 M NaCl. Following
purification, the proteins were concentrated and desalted
using a Millipore UltraFree-15 centrifugal filter device (30
K NMWL).
Sucrose gradient purification was performed by adding 500
íg of WT- or ¢TM-FAAH to a 12.5 mL gradient of 5 to
20% sucrose in buffer 2 [20 mM Hepes (pH 7.8), 0.5%
CHAPS, 1 mM EDTA, 150 mM NaCl, and 1 mM DTT].
The gradients were centrifuged at 39 000 (¢TM-FAAH) or
32 000 rpm (WT-FAAH) for 14 h in a Beckman LE-80K
ultracentrifuge using an SW-40 rotor. Gradients were
drained in 1 mL fractions, and fractions containing FAAH
were identified by SDS-PAGE. Sucrose was removed using
centrifugal filtration devices as described above. The
concentration of purified FAAH was determined with the
Bio-Rad Dc protein assay kit, and this value was correlated
with the UV absorbance of the protein at 280 nm. A solution
with an A280 of 0.8 was found to contain approximately 1
mg/mL recombinant FAAH. This value was used for all
subsequent concentration measurements.
Expression and Purification of GST and TM-GST. Both
proteins were expressed and purified from the E. coli BL21
strain according to the manufacturer’s recommendations
(Amersham Pharmacia Biotech) with the following modifi-
cations. The proteins were solubilized and bound to glu-
tathione-Sepharose in phosphate-buffered saline (PBS) with
1% Triton X-100. Following binding, this buffer was
exchanged for PBS with 0.5% CHAPS. After elution, the
proteins were concentrated by centrifugal filtration and
further purified by gel filtration as described below.
Gel Filtration Chromatography. An AKTA purifier
(Amersham Pharmacia Biotech) was used for all runs. The
desired protein sample was loaded onto a Superdex 200 or
Superose 6 gel filtration column (Amersham Pharmacia
Biotech) equilibrated in buffer 2 at a flow rate of 0.5 mL/
min, and the eluted protein was monitored by UV absorbance
at 280 nm. Collected fractions were assayed for enzyme
activity (FAAH samples only) and analyzed by SDS-PAGE
followed by Coomassie staining and Western blotting to
confirm the identity and purity of the protein contributing
to the observed UV peaks. Molecular mass calibration of
the Superdex 200 column was accomplished using blue
dextran (to determine Vo), thyroglobin (669 kDa, Rs ) 8.6
nm), ferritin (440 kDa, Rs ) 6.3 nm), catalase (232 kDa, Rs
) 5.2 nm), and bovine serum albumin (66 kDa, Rs ) 3.5
nm), where the Rs values are predicted Stokes radii based
on previous studies (29). The Superose 6 column was
calibrated with the same markers except aldolase (158 kDa,
Rs ) 4.6 nm) was used in place of bovine serum albumin.
The elution volumes of the markers were converted to ó
values using the equation ó ) (Ve - Vo)/(VT - Vo), where
Ve is the elution volume, Vo is the column void volume, and
VT is the total column volume (determined by salt peak
elution). The ó values obtained were plotted as a linear
function of log(molecular weight).
LiVer Plasma Membrane Preparation. Rat liver plasma
membranes were isolated from 15 rat livers as described
previously (30), combined, resuspended in 80 mL of buffer
1 with 1% Triton X-100 in place of CHAPS, and Dounce
homogenized. The membrane solution was stirred at 4 °C
for 2 h and then spun at 27 000 rpm for 1 h (SW-28 rotor,
Beckman). The resulting supernatant constituted solubilized
liver plasma membranes.
Enzyme Assays. All reactions were conducted in glass
vials in a total volume of 200 íL. [14C]Oleamide (25-50
íCi/mM) was dissolved in ethanol to 25 times the desired
final concentration, and 4 íL was added to a glass vial with
a glass syringe. Ethanol (5 íL) was added, followed
immediately by 91 íL of reaction buffer [125 mM Tris and
1 mM EDTA (pH 9.0) for Km determinations and COS-7
activity measurements or 50 mM bis-Tris, 50 mM CAPS,
and 50 mM sodium citrate (pH 5-11) for pH profile
measurements]. A solution of 10 íL of 4-4.5 íg/mL
purified WT- or ¢TM-FAAH in buffer 1 with 1% Triton
X-100 (a concentrated stock of the purified enzyme was
diluted into this buffer to obtain the desired concentration)
or 8 íL of the liver plasma membrane preparation was
prepared in 90-92 íL of reaction buffer and the mixture
added to the solution of [14C]oleamide. For Km determina-
tions, 50 íL of the reaction mixture was removed at three
time points with a glass syringe and the reaction quenched
in 300 íL of 0.07 N HCl. For pH-rate profile measurements
and relative rates in COS-7 transfection, the entire reaction
was quenched with 600 íL of 0.07 N HCl. The reaction
products were isolated and analyzed as described previously
(1, 12), with the exception being that quantification was
conducted by phosphorimager analysis (Packard). Km values
were determined from Lineweaver-Burk plots of four
substrate concentrations performed in quadruplicate. Errors
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reflect the sample standard deviations of the four measure-
ments.
Cross-Linking Studies. To normalize the levels of COS-7
expression between WT- and ¢TM-FAAH for cross-linking,
transfections were performed using 1.5 íg of WT-FAAH
cDNA and 5 íg of ¢TM-FAAH cDNA. COS-7 cell extracts
were prepared for cross-linking by isolating membranes and
diluting to approximately 4 mg/mL total protein in 12.5 mM
Hepes (pH 8.0), 1 mM EDTA, and 100 mM NaCl. Five
microliters of bismaleimidohexane (BMH, Pierce) was added
as a 10 stock in DMSO to 50 íL of the dilute protein
solution. The reaction was allowed to proceed at room
temperature for 60 min before quenching with 55 íL of 2
SDS-PAGE loading buffer. The samples were heated to
90 °C for 10 min, and then 15 íL was analyzed by SDS-
PAGE (4 to 12% Tris-glycine gel, Novex) and Western
blotting.
Analytical Ultracentrifugation. The sedimentation proper-
ties of WT- and ¢TM-FAAH were obtained from data
collected on a temperature-controlled Beckman XL-I analyti-
cal ultracentrifuge equipped with an An60Ti rotor and
photoelectric scanner. A double sector cell equipped with
a 12 mm Epon centerpiece and quartz windows was loaded
with 400-420 íL of sample using a blunt-end microsyringe.
Data were collected at rotor speeds of 3000-40000 rpm in
the continuous mode at 20 °C, with a step size of 0.005 cm
and an average of four scans per point. Fewer scans per
point were used when fast sedimenting species were followed
to allow more data sets per unit time to be collected.
Analysis of the Sedimentation Velocity Profiles. The
second moment boundary sedimentation analysis was initially
applied to determine the average sedimentation coefficient,
s (reported in Svedberg units, S, where S represents 10-13
s), for all the species in solution. However, for rigorous
analysis of solutions containing multiple species, the van
Holde-Weischet global boundary analysis was used for
fitting the absorbance data (31). The van Holde-Weischet
global fitting method is especially useful for examining
sample homogeneity and/or heterogeneity and facilitates a
rigorous analysis of complex boundaries of multicomponent
systems, yielding accurate s20,w values for all components
present (32). The contribution of diffusion to the boundary
shape is removed in the van Holde-Weischet analysis by
extrapolating to infinite time (t-1/2 ) 0), thus achieving
resolution between species with similar s values. In the van
Holde-Weischet extrapolation plots, a homogeneous sample
would yield a single y-intercept corresponding to the diffu-
sion-corrected sedimentation coefficient of the species in
solution, while a sample that is heterogeneous would give
multiple y-intercepts. The van Holde-Weischet analysis is
not perturbed by experimentally noisy data, as Demeler and
co-workers have shown that this method faithfully interprets
the experimental data even at noise levels higher than those
that are usually experienced with the XL-I (using simulated
data) (33). The dc/dt time derivative analysis methods for
calculating the apparent sedimentation coefficient distribution
g(*S) developed by Stafford was also used to evaluate and
confirm the homogeneity and/or heterogeneity of the samples
(34, 35).
The observed sedimentation coefficient, s, was corrected
to reflect standard conditions (water at 20 °C) with the
following equation:
where F and Ł are the density and viscosity, respectively, of
water at 20 °C and øj is the partial specific volume of the
protein. The density and viscosity were calculated using
polynomial equations and tables of coefficients (36). The
partial specific volume of WT- and ¢TM-FAAH (0.738 cm3/
g) was estimated on the basis of the partial specific volumes
of the component amino acid residues (37-39).
RESULTS
Expression and Analysis of WT- and ¢TM-FAAH in
COS-7 Cells. PCR was used to generate a rat FAAH cDNA
lacking the coding region for the N-terminal transmembrane
domain (¢TM-FAAH, amino acids 30-579), and this cDNA
was subcloned into the pcDNA3 eukaryotic expression
vector. Homogenates from COS-7 cells transiently trans-
fected with either the ¢TM-FAAH or wild type rat FAAH
(WT-FAAH) cDNA expressed greater than 100-fold more
oleamide hydrolase activity than mock-transfected COS-7
cells (transfected with an empty pcDNA3 vector). Further
biochemical fractionation of the COS-7 cell extracts was
conducted to determine whether the ¢TM-FAAH protein was
associated with membranes. Enzymatic assays on fraction-
ated cell extracts demonstrated that greater than 90% of the
FAAH activity was found to be associated with membrane
fractions for both WT-FAAH (soluble fraction, 6 nmol min-1
mg-1; membrane fraction, 239 nmol min-1 mg-1) and ¢TM-
FAAH (soluble fraction, 7 nmol min-1 mg-1; membrane
fraction, 123 nmol min-1 mg-1). Likewise, Western blotting
using affinity-purified anti-FAAH polyclonal antibodies
identified both WT- and ¢TM-FAAH in these same mem-
brane fractions (Figure 1A, upper panel). When we incu-
bated these membrane fractions with 100 mM Na2CO3 (pH
11.0), we failed to solubilize significant amounts of either
WT- or ¢TM-FAAH as judged by Western blotting (Figure
1A, lower panel). This treatment resulted in the loss of
oleamide hydrolase activity in these fractions. High-salt
washes (1.0 M NaCl) also failed to remove either WT- or
¢TM-FAAH from COS membranes as judged by both
Western blotting and enzyme activity assays (data not
shown). Finally, the results from Western blotting indicated
that the lower overall enzyme activity found in the ¢TM-
FAAH fractions relative to the WT-FAAH fractions could
be ascribed to a lower expression level of the ¢TM-FAAH
protein, rather than being the result of a reduced inherent
activity for the mutant enzyme. In subsequent experiments,
transfection of COS-7 cells with an appropriately reduced
amount of the WT-FAAH construct allowed for equivalent
expression levels of WT- and ¢TM-FAAH as judged by both
Western blotting and enzyme activity assays.
Immunofluorescence studies with COS-7 cells transiently
transfected with either the WT- or ¢TM-FAAH construct
revealed a relatively diffuse staining pattern with the highest
intensity in regions near, but not including, the nucleus
(Figure 1B). This staining is most compatible with pre-
dominate association of both proteins with the endoplasmic
reticulum and/or Golgi apparatus. Overall, the patterns of
staining observed for WT- and ¢TM-FAAH were indistin-
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fluorescence microscopy, suggesting that the two enzymes
were similarly localized in COS-7 cells. Consistent with this
notion, intact WT- and ¢TM-FAAH-transfected cells both
showed efficient and equivalent abilities to hydrolyze olea-
mide added to their incubation media. When transfected
COS-7 cells were incubated in media containing 1 íCi of
[14C]oleamide for 15 min and then harvested and their lipid
contents analyzed by thin layer chromatography (TLC), the
following relative oleamide levels were identified (given as
a percentage of the total lipid radioactivity): mock-trans-
fected, 47% oleamide; ¢TM-FAAH-transfected, 5% olea-
mide; and WT-FAAH-transfected, 7% oleamide.
Despite the overall similarity observed between WT- and
¢TM-FAAH when they are expressed in COS-7 cells, SDS-
PAGE Western blotting experiments did reveal one intriguing
difference between the two proteins. WT-FAAH cell extracts
consistently contained low but significant levels of additional
immunoreactive bands at sizes corresponding to dimeric and
higher-molecular mass (possibly trimeric and/or tetrameric)
forms of the enzyme, while ¢TM-FAAH cell extracts did
not show these species (Figure 2A). The levels of these
SDS-resistant oligomeric forms of WT-FAAH were insensi-
tive to boiling and unaffected by the presence and/or absence
of reducing agents.
Further characterization of this apparent oligomerization
of FAAH was conducted by chemical cross-linking using
bismaleimidohexane (BMH) (Figure 2B). Immunoreactive
bands corresponding to the expected molecular masses of
dimeric species were observed for both WT- and ¢TM-
FAAH after incubations of transfected COS-7 membranes
with 20 íM BMH for 1 h. At higher BMH concentrations
(500 íM), immunoreactive bands consistent with dimeric,
trimeric, and tetrameric species of WT-FAAH and ¢TM-
FAAH were observed, with the relative proportion of the
tetrameric species being significantly greater for WT-FAAH
than for ¢TM-FAAH.
Expression and Purification of ¢TM- and WT-FAAH from
E. coli. To further compare the catalytic and structural
properties of WT- and ¢TM-FAAH, recombinant forms of
each protein were expressed and purified from E. coli.
FIGURE 1: Expression and comparison of WT- and ¢TM-FAAH
in COS-7 cells. (A) Western blot analysis of COS-7 cell extracts
from mock-, WT-, and ¢TM-FAAH-transfected COS-7 cells
identifying significant expression of both FAAH constructs in crude
homogenates. Both WT- and ¢TM-FAAH immunoreactivity as-
sociated with membrane fractions upon cellular fractionation (upper
panel). Following a 30 min wash with 100 mM Na2CO3, both WT-
and ¢TM-FAAH were retained in membrane fractions (H, homo-
genates; S, soluble protein fraction; P, membrane fraction; SC,
soluble fraction following Na2CO3 wash; PC, membrane fraction
following Na2CO3 wash). Molecular mass standards are indicated
in kilodaltons. (B) Immunofluorescence microscopy of transfected
COS-7 cells with anti-FAAH antibodies. A similar pattern of diffuse
membranous staining was observed for both WT- and ¢TM-FAAH.
FIGURE 2: Evidence for FAAH oligomerization in transfected
COS-7 cell extracts. (A) Western blot analysis of WT- (center lane)
and ¢TM-FAAH (right lane) present in isolated COS-7 membranes.
Samples were loaded under reducing, denaturing conditions (5%
â-mercaptoethanol and 2% SDS) on a 10% polyacrylamide gel.
Note the presence of potential oligomeric immunoreactive bands
at g120 kDa for WT-FAAH which are not present in the ¢TM-
FAAH sample. (B) Western blot analysis of WT- and ¢TM-FAAH
from COS-7 membranes following a 1 h incubation with bisma-
leimidohexane (BMH) at the indicated concentrations (in micro-
molar). Proteins were loaded on a 4 to 12% polyacrylamide gradient
gel. Molecular mass standards are indicated in kilodaltons.
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Expression of ¢TM-FAAH in E. coli was accomplished by
using the pTrcHisA vector to generate an N-terminal His6-
tagged fusion protein containing amino acids 32-579 of
FAAH. WT-FAAH was also successfully expressed with
an N-terminal His tag; however, subsequent attempts to
purify this form of the enzyme proved to be exceedingly
difficult, and therefore, the enzyme was expressed as a
C-terminal His6-tagged fusion protein. While a portion of
the expressed enzymes was observed by Western blotting
in insoluble inclusion bodies under all conditions, significant
quantities of active protein could be recovered after a 4 h
induction period with 1 mM IPTG. Induction for longer
times resulted in a progressive loss of recoverable active
FAAH, culminating at an induction time of 24 h where no
active enzyme was isolated and all FAAH immunoreactivity
was identifed in inclusion bodies. These results highlight
the delicate nature of efficiently expressing eukaryotic
membrane proteins in E. coli and indicate that carefully
controlled induction protocols may facilitate the successful
recombinant expression of other membrane proteins in this
organism. Following cell lysis and solubilization with 1%
Triton X-100, purification of the recombinant proteins was
achieved using sequential Talon Metal Affinity Resin (Clon-
tech) and heparin-agarose chromatography steps (Figure 3).
Typical yields of purified WT- and ¢TM-FAAH ranged from
1 to 1.5 mg of protein per liter of culture volume.
Enzymology of Purified WT- and ¢TM-FAAH. To evalu-
ate the effects of transmembrane domain deletion and/or
recombinant expression on the enzymatic properties of
FAAH, the purified recombinant proteins were compared to
the native protein from rat liver. The two recombinant
enzymes were found to exhibit pH-rate profiles nearly
identical to that of the native enzyme, with maximal activity
at pH 9.5 (Figure 4A). The only notable difference in the
pH-rate profiles of the recombinant FAAHs was observed
at pH 11.0, where the native enzyme was still significantly
active while recombinant WT- and ¢TM-FAAH were
completely inactive. On a similar note, we have observed
that a 100 mM Na2CO3 incubation (30 min at 4 °C and pH
11.0) destroyed the catalytic activity of both WT- and ¢TM-
FAAH derived from transfected COS-7 cells, whereas the
native liver-isolated FAAH was stable to this treatment.
Lineweaver-Burk plots of the purified WT- and ¢TM-
FAAH at pH 9.0 gave Km values for oleamide of 23 ( 8
and 12 ( 2 íM, respectively (Figure 4B). These values were
similar to the Km value of 31 ( 3 íM found for native
solubilized rat liver FAAH (40) and also compared well with
previously reported Km values for oleamide of 5 íM from
nonsolubilized rat liver plasma membrane FAAH (30) and
9 and 14 íM from N18 mouse neuroblastoma-derived FAAH
(3). On the basis of the estimated protein concentrations in
the WT- and ¢TM-FAAH reactions, kcat values of 7.1 and
3.3 s-1 were calculated for each enzyme, respectively, giving
nearly identical kcat/Km values of 3.1  105 M-1 s-1 for WT-
FAAH and 2.8  105 M-1 s-1 for ¢TM-FAAH. These kcat/
Km values indicate that the efficiency of hydrolysis of
oleamide by FAAH is comparable to that of most known
protease- and amidase-catalyzed reactions.
Characterization of FAAH Self-Association. Upon puri-
fication from E. coli, the presence of SDS-resistant dimers
of WT-FAAH, but not ¢TM-FAAH, was again observed
by SDS-PAGE and Western blotting (Figure 5A). On 5 to
20% linear sucrose gradients, ¢TM-FAAH migrated near
the 11.4 S standard (catalase), while WT-FAAH migrated
as a very diffuse band beginning slightly larger than the 11
S catalase standard and extending beyond the 18 S thyro-
globin standard (data not shown). Sucrose gradient-purified
WT- and ¢TM-FAAH were subjected to sedimentation
FIGURE 3: Expression and purification of ¢TM-FAAH from E.
coli. Triton X-100-solubilized E. coli extracts (lane 1) containing
N-terminal His-tagged ¢TM-FAAH prior to (lane 1) and after (lane
2) incubation with cobalt affinity resin. Bound FAAH was eluted
with 50 (lane 3), 80 (lane 4), and 200 mM (lane 5) imidazole.
Elution with a single volume of 200 mM imidazole provided similar
results. The elutions were combined (lane 7) and applied to a
heparin-agarose column. Heparin flow through (lane 8) indicated
efficient binding of ¢TM-FAAH. The column was washed with
300 mM NaCl (lane 9) and purified ¢TM-FAAH eluted with 700
mM NaCl (lane 10). Molecular mass standards (lane 6) are from
top to bottom: 207, 121, 81, 51, 34, and 29 kDa.
FIGURE 4: Enzymatic characterization of recombinant purified WT-
and ¢TM-FAAH. (A) The pH-rate profiles of solubilized rat liver
FAAH (solid line), WT-FAAH (dashed line), and ¢TM-FAAH
(stipled line). (B) Relevant kinetic parameters obtained for recom-
binant WT-FAAH, ¢TM-FAAH, and native rat liver FAAH. ND,
not determined.
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velocity and equilibrium ultracentrifugation analysis to
characterize the self-association properties of these proteins
(Figure 5B-E). Results from sedimentation velocity experi-
ments indicated that detergent-protein complexes of ¢TM-
FAAH existed primarily as a single species with an s20,w of
11.2 ( 0.2 S (Figure 5C). The 11.2 S species was found to
be the dominant species over a concentration range of 1.25-
10 íM. Attempts to determine the molecular mass of ¢TM-
FAAH either by direct fitting of the absorbance profiles or
from time derivative g(*S) plots were complicated by small
quantities (e5%) of apparent aggregates which hindered the
accurate evaluation of the diffusion coefficient. These
analyses, however, typically yielded predicted molecular
masses for ¢TM-FAAH between 165 and 260 kDa. Sedi-
mentation equilibrium studies of ¢TM-FAAH were also
complicated by an apparent self-association of the protein
as it concentrated toward the bottom of the cell (data not
shown); however, the smallest species observed in these
studies, 260 kDa, was consistent with results obtained from
sedimentation velocity analysis.
Detergent-protein complexes of WT-FAAH behaved as
much larger 15-28 S species on the basis of sedimentation
velocity analysis (Figure 5E). At all concentrations (from
2.5 to 10 íM) and under all conditions tested, the 15 S
species was the smallest observed for WT-FAAH, even when
the sample was analyzed in the presence of 0.4 M urea (data
not shown). Time derivative analysis of the concentration
profile indicated that the WT-FAAH sample consisted of
FIGURE 5: Characterization of the oligomeric states of recombinant WT- and ¢TM-FAAH. (A) WT-FAAH migrated as monomeric and
dimeric species under reducing, denaturing conditions, while ¢TM-FAAH migrated as only a monomeric species. Molecular mass standards
are indicated in kilodaltons. Sedimentation profiles (B and D; for clarity, scans shown are 7 min apart) and van Holde-Weischet extrapolation
plots (C and E) of sedimentation velocity data collected at 40 000 rpm with 5 íM ¢TM-FAAH (B and C) and 30 000 rpm with 5 íM
WT-FAAH (D and E). ¢TM-FAAH was a single 11 S species, while WT-FAAH behaved as a heterogeneous distribution of 15-28 S
species. (F) Migration of ¢TM- (dashed line) and WT-FAAH (solid line) on Superose 6 gel filtration. Molecular mass standards are indicated
in kilodaltons.
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multiple species with two major sedimenting forms at 17
and 24 S that were partially resolved at later time points in
the run. Due to the heterogeneity of species in the WT-
FAAH sample, accurate determination of the molecular mass
or oligomeric state of the protein could not be achieved.
In efforts to account for the possibility of bound detergent
affecting the observed sedimentation velocity profiles of the
two proteins, sedimentation velocity analysis of the FAAH
proteins was performed in the presence of the neutrally
buoyant detergent n-octyl pentaoxyethylene at 15 mM (C8E5,
Bachem), in place of CHAPS (41). Both WT- and ¢TM-
FAAH were observed to aggregate to a much larger extent
in this detergent than in CHAPS, with 15-20% of each
protein sample sedimenting quickly as high-molecular mass
aggregates. However, time derivative analysis of the slower
sedimenting boundary revealed essentially the same species
for ¢TM-FAAH (12 S) and WT-FAAH (16-26 S) as those
obtained in CHAPS.
Gel filtration chromatography of the purified FAAH
samples also demonstrated that both WT- and ¢TM-FAAH
behaved as large oligomeric species. WT-FAAH eluted in
the void volume of a Superdex 200 column (Amersham
Pharmacia Biotech), just before the 669 kDa thyroglobin
standard, while ¢TM-FAAH eluted as a single peak slightly
ahead of the 440 kDa ferritin standard with a predicted
molecular mass of approximately 480 kDa (data not shown).
A C-terminally His-tagged ¢TM-FAAH displayed an elution
profile identical to that of the N-terminally His-tagged ¢TM-
FAAH, indicating that the position of the histidine tag did
not affect the migration properties of the protein. On a
Superose 6 column, WT-FAAH eluted as a broad peak with
a predicted molecular mass of approximately 850 kDa, while
¢TM-FAAH behaved as a 420 kDa species (Figure 5F).
Analysis of the proteins loaded over a 100-fold initial
concentration range (2-200 íM) yielded identical elution
profiles (data not shown). Additionally, both proteins were
analyzed in the presence of 2 mM lauryldimethylamine oxide
(LDAO) in place of CHAPS as the buffer detergent and
showed the same elution profiles under these conditions (data
not shown).
Characterization of a FAAH Transmembrane Domain-
GST Fusion Protein. To evaluate whether the presence of
FAAH’s N-terminal transmembrane domain region was
sufficient to induce specific self-association, a GST fusion
protein was constructed with FAAH’s 39 N-terminal amino
acid residues attached to the N terminus of GST (TM-GST).
The fusion protein was expressed, purified by sequential
glutathione-Sepharose and gel filtration chromatography
steps, and analyzed by immunoblotting, gel filtration, and
sedimentation velocity ultracentrifugation.
Results from SDS-PAGE Western blotting experiments
revealed the presence of large amounts of SDS-resistant
dimeric TM-GST, as well as faint larger bands potentially
corresponding to trimeric and/or tetrameric species (Figure
6A). Purified GST was not found to form any SDS-resistant
oligomers. The relative amounts of the TM-GST SDS-
resistant oligomers were somewhat temperature dependent
(data not shown), but even after boiling the protein for 10
min in SDS-PAGE loading buffer, a significant amount of
SDS-resistant dimer was still observed. The TM-GST
fusion protein could be fully separated from GST by gel
filtration using a Superdex 200 column (Figure 6B). GST
eluted slightly later than the 65 kDa marker (bovine serum
albumin), as expected for its predicted dimeric size of 56
kDa, while TM-GST ran as an apparent heterogeneous
population of species eluting partially in the void volume of
the column and peaking slightly before the 440 kDa ferritin
marker. Sedimentation velocity ultracentrifugation analysis
of TM-GST supported the results from gel filtration
indicating that the TM-GST sample contained a heteroge-
neous distribution of large oligomeric species (Figure 6C).
The majority of the species observed were between 7 and
22 S, while trace amounts of larger oligomers were also
apparent. In contrast, GST behaved as a single 3.5 S species
with a predicted molecular mass of 46 kDa.
DISCUSSION
The amidase signature sequence enzymes represent a
growing family of proteins found in a variety of both
prokaryotic and eukaryotic organisms. Members of this
enzyme family include indoleacetamidase from the plant
pathogen Agrobacterium tumefaciens (10), which is involved
in the production of the plant hormone indoleacetic acid (42),
and acetamidase, a highly regulated enzyme from Aspergillus
nidulans (11, 43) that allows this organism to use acetamide
as its sole carbon and nitrogen source (44, 45). A single
mammalian amidase signature sequence enzyme has been
characterized to date, fatty acid amide hydrolase (FAAH),
which is responsible for degrading bioactive fatty acid amides
such as anandamide and oleamide (1). Despite the apparent
importance of the amidase signature sequence family in a
variety of signaling cascades, little is presently known about
the catalytic and structural features of these enzymes. In
this regard, a recent mutagenesis study conducted on the
Rhodoccocus rhodochrous J1 amidase (46), indicates that
this enzyme family does not hydrolyze amides by a classi-
cally defined protease mechanism and instead may operate
by a novel mode of catalysis.
An apparently unique feature of FAAH when compared
to other characterized members of the amidase signature
family is the presence of a predicted N-terminal transmem-
brane domain (amino acids 9-29). To examine the role of
this domain in FAAH structure and function, N-terminal
transmembrane domain deletion constructs were produced
that allowed for expression and analysis of this mutant
protein (¢TM-FAAH) in both COS-7 cells and E. coli.
Expression of ¢TM-FAAH in COS-7 cells demonstrated that
deletion of FAAH’s predicted N-terminal transmembrane
domain did not abolish FAAH’s ability to interact strongly
with membranes. It is perhaps not unexpected that extensive
membrane interactions beyond those provided by a single
membrane-spanning domain would be exhibited by FAAH.
Such strong membrane associations in the absence of
transmembrane domains have previously been observed for
other enzymes such as prostaglandin H synthase (47) and
squalene cyclase (48), which bind the membrane through
hydrophobic patches that penetrate one leaflet of the bilayer.
These membrane interactions are thought to be central to
efficient enzymatic catalysis, facilitating both substrate
binding and product release (48). A FAAH-membrane
association similar in type to the membrane contacts
displayed by prostaglandin H synthase and squalene cyclase
could allow bilayer-embedded fatty acid amides direct access
to FAAH’s catalytic machinery.
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Having deduced that FAAH does not require its N-terminal
transmembrane domain to interact strongly with membranes,
we arrived at the following question: what function might
this region of the enzyme serve? Initial enzymatic studies
of WT- and ¢TM-FAAH from transfected COS-7 cells
demonstrated that both enzymes were catalytically active in
crude homogenates. Moreover, oleamide added to both WT-
and ¢TM-FAAH-transfected COS-7 cells in culture was
more rapidly degraded than oleamide added to mock-
transfected COS-7 cells, indicating that ¢TM-FAAH was
able to access its substrates in vivo. Finally, the enzymatic
properties of purified recombinant WT- and ¢TM-FAAH
were nearly identical, indicating that the N-terminal trans-
membrane domain of FAAH does not play a direct role in
the catalytic activity of the enzyme.
One notable difference observed between WT- and ¢TM-
FAAH, both in COS-7 and in E. coli expression systems,
was the ability of WT-FAAH, but not ¢TM-FAAH, to form
SDS-resistant oligomers. Cross-linking of the two enzymes
on COS-7 cell membranes with the sulfhydryl reactive cross-
linker BMH revealed that both enzymes appeared to be
oligomeric when membrane-bound. Additionally, cross-
linking of WT-FAAH consistently generated a larger propor-
tion of a tetrameric species than cross-linking of ¢TM-
FAAH, perhaps indicating differences in the oligomerization
properties for each enzyme. However, given that the
transmembrane domain of FAAH possesses two potentially
cross-linkable cysteines, the differences in the cross-linking
profiles observed for the two enzymes do not necessarily
reflect differences in their respective oligomerization states.
Sedimentation velocity analytical ultracentrifugation and
gel filtration analysis of the purified recombinant enzymes
confirmed the ability of FAAH to form homo-oligomeric
complexes, and indicated differences in the relative oligo-
meric states of WT- and ¢TM-FAAH. In buffer solutions
containing 0.5% CHAPS, ¢TM-FAAH sedimented as a
single oligomeric species with an s value of 11.2 S, and
eluted on gel filtration columns slightly before the 440 kDa
marker while WT-FAAH sedimented as a heterogeneous
distribution of species with s values ranging from 15 to 28
S and eluted as a broad peak ahead of the 669 kDa marker.
The absence of any observed protein concentration effects
FIGURE 6: Characterization of assembly of a FAAH transmembrane domain-GST fusion protein (TM-GST). (A) SDS-resistant oligomeric
species of TM-GST (right lanes) but not control GST (left lanes) were observed by Western blotting. A low and high exposure of each
protein sample is shown. Proteins were run on a 4 to 20% polyacrylamide gradient gel. Molecular mass standards are indicated in kilodaltons.
(B) Gel filtration analysis of GST (solid line) and TM-GST (dashed line) indicating the presence of large oligomeric species for TM-
GST. (C and D) Time derivative g(*S) analysis of the concentration profile of GST (C) and TM-GST (D) from sedimentation velocity
data. Note the different scales for the x-axis (S*) of panels C and D.
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for the oligomeric sizes of WT- and ¢TM-FAAH suggests
that the FAAH is likely to be an oligomeric protein at the
lower enzyme concentrations used in enzyme assays and
found in vivo.
The molecular mass of ¢TM-FAAH determined directly
from the sedimentation velocity data varied from 165 to 260
kDa depending on the method employed (direct fitting or
time derivative analysis). These values were significantly
smaller than the molecular masses estimated by gel filtration
(420 kDa on Superose 6 and 480 kDa on Superdex 200).
Using the Stokes radius obtained from gel filtration (relative
to the standards of known Stokes radii) to calculate a
diffusion coefficient, and the s20,w value determined by
sedimentation velocity analysis, a molecular mass of 300-
350 kDa was calculated for the detergent-enzyme complex.
Sedimentation studies in the neutrally buoyant detergent C8E5
and gel filtration in LDAO yielded s values and elution
profiles nearly identical to those found in CHAPS, indicating
that the contribution of bound detergent to the measured
hydrodynamic parameters was likely relatively small. Thus,
depending on the exact method employed for analysis of the
data, the predicted oligomeric state of the enzyme ranged
from trimeric to heptameric. On the basis of the apparent
discrepancies between the these methods, defining the precise
oligomeric state of ¢TM-FAAH will require further study.
These data, however, do support a trimeric or larger
oligomeric state for this enzyme.
Both sedimentation velocity analysis and gel filtration
studies suggested that WT-FAAH, when expressed in E. coli,
was a heterogeneous distribution of oligomeric species, all
of which were apparently larger than the species found for
¢TM-FAAH. It is presently not clear whether the hetero-
geneity of this sample is relevant to the state of the enzyme
in vivo. The interactions giving rise to the heterogeneous
population are certainly specific, as the species observed were
consistent in several independent preparations and under
several conditions. The oligomerization of ¢TM-FAAH, in
the absence of the transmembrane domain, suggests that
multiple oligomerization sites exist in FAAH. It is possible
that the prokaryotic translational machinery is unable to
properly assemble the transmembrane domain containing
enzyme into its native oligomeric state due to the complexity
of interactions found for the protein. This possibility is
supported by the observation that the relative amount of SDS-
resistant dimer observed for the E. coli-expressed WT-FAAH
was consistently higher than that found in COS-7 cells, while
SDS-resistant oligomeric forms larger than dimer were rarely
observed with the E. coli-derived WT-FAAH. Further
studies will be required to determine whether self-association
through FAAH’s transmembrane domain causes FAAH to
form higher-order oligomers in vivo, or instead serves to
stabilize the oligomeric state observed in its absence.
The ability of FAAH’s transmembrane domain region to
self-associate was further studied by fusing the 39 N-terminal
amino acids of FAAH to the N terminus of GST. As
expected for a homo-oligomeric interaction, the TM-GST
construct was able to form SDS-resistant dimers and larger
forms similar to WT-FAAH. These species were present
even in crude bacterial lysates, indicating that the self-
association was specific (data not shown). Since GST is a
dimer with its N termini facing in opposite directions (49),
we anticipated that self-association through FAAH’s trans-
membrane domain might result in polymerization of TM-
GST into very large oligomers (50). This was found to be
the case for TM-GST based on size exclusion chromatog-
raphy and sedimentation velocity analysis. While this
polymerization of TM-GST provided an easily detectable
change in oligomeric state, this fusion protein did not allow
for a means of assessing whether FAAH’s transmembrane
domain could oligomerize to states higher than dimers.
Further structural and biochemical studies with monomeric
fusion proteins containing the FAAH transmembrane domain
may assist in elucidating the stoichiometry of this association.
It is clear from these studies that FAAH’s transmembrane
domain region can function as an autonomous oligomeriza-
tion site. The ability of transmembrane domains to form
specific, and often SDS-resistant, homo-oligomeric structures
has been demonstrated for a small but growing family of
proteins (51). The most well studied example of a protein
that forms transmembrane domain-mediated homodimers is
glycophorin A, whose transmembrane domain, like that of
FAAH, is sufficient to induce dimerization in the context of
a heterologous fusion protein (52). Interestingly, recent
structural information on a dimer of the glycophorin A
transmembrane domain has shown that van der Waals
interactions alone suffice to generate stable and specific
molecular self-association (53).
Specific transmembrane domain interactions of single
membrane helix proteins have generally been observed in
receptor proteins. Thus, it is intriguing that an enzyme like
FAAH would display this means of self-association, espe-
cially given that deletion of FAAH’s transmembrane domain
does not appear to affect enzymatic activity. It is possible
that the presence of FAAH’s transmembrane domain is
necessary for the localization and/or stability of the enzyme
in its native environment. An alternative, and perhaps more
provocative hypothesis, however, is that this added level of
structural complexity could be indicative of additional roles
for FAAH in cell signaling processes.
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